East Meets West in the Treatment of Gastric Cancer
- 1 November 2007
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (18), 1863-1865
- https://doi.org/10.1056/nejme078182
Abstract
Gastric cancer is a leading cause of illness and death from cancer worldwide, with nearly a million new cases diagnosed each year and a 5-year survival rate of less than 20% among patients in most parts of the world other than Japan, where the rate is closer to 60%.1 Early dissemination of the disease through the lymphatic system, blood, and peritoneum has limited the ability of optimal surgery to cure, except in patients with relatively early tumors. The detection of early disease has remained elusive in Europe and North America, but there has been some success in the East, particularly . . .This publication has 11 references indexed in Scilit:
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineNew England Journal of Medicine, 2007
- Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912)Journal of Clinical Oncology, 2007
- Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trialJournal of Clinical Oncology, 2007
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumorsAnti-Cancer Drugs, 2004
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionNew England Journal of Medicine, 2001
- A Systematic Overview of Chemotherapy Effects in Gastric CancerActa Oncologica, 2001
- Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trialsAnnals Of Oncology, 2000
- Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trialsEuropean Journal of Cancer, 1999